Sulfasalazine: My study [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-05-28 12:04  – Posting: # 20304
Views: 984

Hi Irene,

» Have anyone here ever conducted Bioequivalence study of Sulfasalazine?

Yes. My results (T1: 1×4 500 mg IR, T2: 1×4 500 mg enteric coated, R: 2,000 mg suspension, six-sequence Williams’ design, sampling for 60 hours, washout two weeks, 24 eligible subjects, plasma and urine). This study was performed for the originator. Both test products showed lower bioavailabilities of sulfasalazine and 5-ASA, whereas sulfapyridine and N-acetylsulfapyridine were BE. CVs for plasma:Given the high variabilities of Sulfasalazine and 5-ASA I suggest reference-scaling.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
20,034 posts in 4,233 threads, 1,378 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 01:50 CET

Maturity is the capacity to endure uncertainty.    John Finley

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5